Potentiation of glucocorticoid activity in hypoxia through induction of the glucocorticoid receptor

Journal of Immunology

Volumn 174, Issue 4, 2005, Pages 2250-2257

  Leonard, Martin O ^a   Godson, Catherine ^a   Brady, Hugh R ^a   Taylor, Cormac T ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; SMALL INTERFERING RNA;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; GENE EXPRESSION REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; HYPOXEMIA; INFLAMMATION; KIDNEY PROXIMAL TUBULE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 13544249964     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.4.2250     Document Type: Article

References (45)

1. Genuth, S. M. 2004. The adrenal glands. In Physiology. R. M. Berne, ed. Mosby, St Louis, pp 883-919.
2. Neeck, G., R. Renkawitz, and M. Eggert. 2002. Molecular aspects of glucocorticoid hormone action in rheumatoid arthritis. Cytokines Cell. Mol. Ther. 7:61.
3. Nikolaus, S., U. Folscn, and S. Schreiber. 2000. Immunopharmacology of 5-aminosalicylic acid and of glucocorticoids in the therapy of inflammatory bowel disease. Hepatogastroenterology 47:71.
4. Schaaf, M. J., and J. A. Cidlowski. 2002. Molecular mechanisms of glucocorticoid action and resistance. J. Steroid Biochem. Mol. Biol. 83:37.
5. Newton, R. 2000. Molecular mechanisms of glucocorticoid action: what is important? Thorax 55:603.
6. Adcock, I. M., and S. J. Lane. 2003. Corticosteroid-insensitive asthma: molecular mechanisms. J. Endocrinol. 178:347.
7. Webster, J. C., and J. A. Cidlowski. 1999. Mechanisms of glucocorticoid-receptor-mediated repression of gene expression. Trends Endocrinol. Metab. 10:396.
8. Barnes, P. J. 1998. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci. 94:557.
9. Taylor, C. T., and S. P. Colgan. 1999. Therapeutic targets for hypoxia-elicited pathways. Pharm. Res. 16:1498.
10. Huang, L. E., and H. F. Bunn. 2003. Hypoxia-inducible factor and its biomedical relevance. J. Biol. Chem. 278:19575.
11. Comerford, K. M., M. O. Leonard, J. Karhausen, R. Carey, S. P. Colgan, and C. T. Taylor. 2003. Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia. Proc. Natl. Acad. Sci. USA 100:986.
12. Basu, M., R. C. Sawhney, S. Kumar, K. Pal, R. Prasad, and W. Selvamurthy. 2002. Glucocorticoids as prophylaxis against acute mountain sickness. Clin. Endocrinol. 57:761.
13. Bauer, A., F. Tronche, O. Wessely, C. Kellendonk, H. M. Reichardt, P. Steinlein, G. Schutz, and H. Beug. 1999. The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev. 13:2996.
14. von Lindern, M., W. Zauner, G. Mellitzer, P. Steinlein, G. Fritsch, K. Huber, B. Lowenberg, and H. Beug. 1999. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood 94:550.
15. Fisher, J. W. 1998. A quest for erythropoietin over nine decades. Annu. Rev. Pharmacol. Toxicol. 38:1.
16. Limbourg, F. P., Z. Huang, J. C. Plumier, T. Simoncini, M. Fujioka, J. Tuckermann, G. Schutz, M. A. Moskowitz, and J. K. Liao. 2002. Rapid non-transcriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J. Clin. Invest. 110:1729.
17. Glanemann, M., R. Strenziok, R. Kuntze, S. Munchow, N. Dikopoulos, F. Lippek, J. M. Langrehr, M. Dietel, P. Neuhaus, and A. K. Nussler. 2004. Ischemic preconditioning and methylprednisolone both equally reduce hepatic ischemia/reperfusion injury. Surgery 135:203.
18. Ryan, M. J., G. Johnson, J. Kirk, S. M. Fuerstenberg, R. A. Zager, and B. Torok-Storb. 1994. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int. 45:48.
19. Leonard, M. O., D. C. Cottell, C. Godson, H. R. Brady, and C. T. Taylor. 2003. The role of HIF-1α in transcriptional regulation of the proximal tubular epithelial cell response to hypoxia. J. Biol. Chem. 278:40296.
20. Taylor, C. T., N. Fueki, A. Agah, R. M. Hershberg, and S. P. Colgan. 1999. Critical role of cAMP response element binding protein expression in hypoxia-elicited induction of epithelial tumor necrosis factor-α. J. Biol. Chem. 274:19447.
21. Mitchell, D., K. Rodgers, J. Hanly, B. McMahon, H. R. Brady, F. Martin, and C. Godson. 2004. Lipoxins inhibit Akt/PKB activation and cell cycle progression in human mesangial cells. Am. J. Pathol. 164:937.
22. Nunez, B. S., and W. V. Vedeckis. 2002. Characterization of promoter 1B in the human glucocorticoid receptor gene. Mol. Cell. Endocrinol. 189:191.
23. Hagen, T., C. T. Taylor, F. Lam, and S. Moncada. 2003. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1α. Science 302:1975.
24. Bamberger, C. M., H. M. Schulte, and G. P. Chrousos. 1996. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr. Rev. 17:245.
25. Mukaida, N., M. Morita, Y. Ishikawa, N. Rice, S. Okamoto, T. Kasahara, and K. Matsushima. 1994. Novel mechanism of glucocorticoid-mediated gene repression: nuclear factor-κB is target for glucocorticoid-mediated interleukin 8 gene repression. J. Biol. Chem. 269:13289.
26. Ferrara, N. 2002. VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer. 2:795.
27. Nauck, M., G. Karakiulakis, A. P. Perruchoud, E. Papakonstantinou, and M. Roth. 1998. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur. J. Pharmacol. 341:309.
28. Vanderbilt, J. N., R. Miesfeld, B. A. Maler, and K. R. Yamamoto. 1987. Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol. Endocrinol. 1:68.
29. Pepin, M. C., and N. Barden. 1991. Decreased glucocorticoid receptor activity following glucocorticoid receptor antisense RNA gene fragment transfection. Mol. Cell. Biol. 11:1647.
30. Sandeep, T. C., and B. R. Walker. 2001. Pathophysiology of modulation of local glucocorticoid levels by 11β-hydroxysteroid dehydrogenases. Trends Endocrinol. Metab. 12:446.
31. Heiniger, C. D., R. M. Kostadinova, M. K. Rochat, A. Serra, P. Ferrari, B. Dick, B. M. Frey, and F. J. Frey. 2003. Hypoxia causes down-regulation of 11β-hydroxysteroid dehydrogenase type 2 by induction of Egr-1. FASEB J. 17:917.
32. Diederich, S., E. Eigendorff, P. Burkhardt, M. Quinkler, C. Bumke-Vogt, M. Rochel, D. Seidelmann, P. Esperling, W. Oelkers, and V. Bahr. 2002. 11β-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids. J. Clin. Endocrinol. Metab. 87:5695.
33. Silva, C. M., F. E. Powell-Oliver, C. M. Jewell, M. Sar, V. E. Allgood, and J. A. Cidlowski. 1994. Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid. Steroids 59:436.
34. Kanelakis, K. C., and W. B. Pratt. 2003. Regulation of glucocorticoid receptor ligand-binding activity by the hsp90/hsp70-based chaperone machinery. Methods Enzymol. 364:159.
35. Tago, K., F. Tsukahara, M. Naruse, T. Yoshioka, and K. Takano. 2004. Hsp90 inhibitors attenuate effect of dexamethasone on activated NF-κB and AP-1. Life Sci. 74:1981.
36. Kanelakis, K. C., D. S. Shewach, and W. B. Pratt. 2002. Nucleotide binding states of hsp70 and hsp90 during sequential steps in the process of glucocorticoid receptor.hsp90 heterocomplex assembly. J. Biol. Chem. 277:33698.
37. Rangarajan, P. N., K. Umesono, and R. M. Evans. 1992. Modulation of glucocorticoid receptor function by protein kinase A. Mol. Endocrinol. 6:1451.
38. Zong, J., J. Ashraf, and E. B. Thompson. 1990. The promoter and first, untranslated exon of the human glucocorticoid receptor gene are GC rich but lack consensus glucocorticoid receptor element sites. Mol. Cell. Biol. 10:5580.
39. Nobukuni, Y., C. L. Smith, G. L. Hager, and S. D. Detera-Wadleigh. 1995. Characterization of the human glucocorticoid receptor promoter. Biochemistry 34:8207.
40. Warriar, N., N. Page, and M. V. Govindan. 1996. Expression of human glucocorticoid receptor gene and interaction of nuclear proteins with the transcriptional control element. J. Biol. Chem. 271:18662.
41. Breslin, M. B., and W. V. Vedeckis. 1998. The human glucocorticoid receptor promoter upstream sequences contain binding sites for the ubiquitous transcription factor, Yin Yang 1. J. Steroid Biochem. Mol. Biol. 67:369.
42. Newton, T. R., N. M. Patel, P. Bhat-Nakshatri, C. R. Stauss, R. J. Goulet, Jr., and H. Nakshatri. 1999. Negative regulation of transactivation function but not DNA binding of NF-κB and AP-1 by IκBβ1 in breast cancer cells. J. Biol. Chem. 274:18827.
43. Gille, J., K. Reisinger, B. Westphal-Varghese, and R. Kaufmann. 2001. Decreased mRNA stability as a mechanism of glucocorticoid-mediated inhibition of vascular endothelial growth factor gene expression by cultured keratinocytes. J. Invest. Dermatol. 117:1581.
44. Kodama, T., N. Shimizu, N. Yoshikawa, Y. Makino, R. Ouchida, K. Okamoto, T. Hisada, H. Nakamura, C. Morimoto, and H. Tanaka. 2003. Role of the glucocorticoid receptor for regulation of hypoxia-dependent gene expression. J. Biol. Chem. 278:33384.
45. Hellwig-Buergel, T., A. Wagner, and W. Jelkmann. 2004. Biology of hypoxia: the role of oxygen sensing in development, normal function and disease. In Keystone Symposium March 25-30. Abstract 203. R. A. Johnson, A. Giacci, and M. C. Simon, ed. Steamboat Springs, Colorado, p. 79.